Yes, semaglutide is itself a peptide (a GLP-1 receptor agonist)
Patients were grouped into nondiabetic or type 2 diabetic cohorts, then each patient on a GLP-1 was matched to four patients who were not prescribed a GLP-1 based on age at bone density disorder diagnosis, total observed time with the condition, and number of prior fractures
Papers were excluded if they were review papers, if the study was conducted only on animals, if there was no measurement of ghrelin or GLP-1, or administration of an agonist or antagonist for the respective receptors, or when the hormonal measure or manipulation was not related to the reward response
doi: 10.1056/NEJMoa2206038 83 US National Institutes of Health
Both can increase the risk of skin cancer
Learn more about why Jabby is the best GLP-1 app available